ENTITY

Mabwell (Shanghai) Bioscience (MAB HK)

11
Analysis
Health Care • China

•15 May 2025 07:55

Pre-IPO Mabwell (Shanghai) Bioscience - The ADC Technology Is Outdated

​Mabwell is struggling with lower-than-expected commercialization performance and outdated ADC technology. The pipeline lacks competitiveness,...

Logo
394 Views
Share
x